It has been reported that genetic disruption or pharmacological inhibition of the AT1R attenuates atherosclerosis and improves endothelial function in diabetic ApoE−/− mice via the PPARγ pathway [37]. This evidence concerns the gene AGTR1 and atherosclerosis.